Trials / Completed
CompletedNCT01640353
Sacroiliac Joint Fusion With iFuse Implant System (SIFI)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 194 (actual)
- Sponsor
- SI-BONE, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the use of the iFuse Implant System to treat degenerative sacroiliitis (arthritis of the SI joint) and sacroiliac disruption (abnormal separation or tearing of the sacroiliac joint). The iFuse Implant System (iFuse device) is a medical device that is surgically implanted into the sacroiliac (SI) joint during a minimally invasive surgical procedure (one that uses a smaller incision and less damage to the skin and other tissues than standard surgery). The purpose of implanting the device is to stabilize and fuse the SI joint.
Conditions
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2015-01-01
- Completion
- 2016-02-01
- First posted
- 2012-07-13
- Last updated
- 2017-03-24
- Results posted
- 2017-03-24
Locations
26 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01640353. Inclusion in this directory is not an endorsement.